{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T01:37:27Z","timestamp":1791596247929,"version":"4.3.4"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,7]],"date-time":"2020-12-07T00:00:00Z","timestamp":1607299200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EClinicalMedicine"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.eclinm.2020.100694","type":"journal-article","created":{"date-parts":[[2020,12,23]],"date-time":"2020-12-23T09:53:55Z","timestamp":1608717235000},"page":"100694","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"special_numbering":"C","title":["Benznidazole decreases the risk of chronic Chagas disease progression and cardiovascular events: A long-term follow up study"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5430-7222","authenticated-orcid":false,"given":"Alejandro M.","family":"Hasslocher-Moreno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto M.","family":"Saraiva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz H.C.","family":"Sangenis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio S.","family":"Xavier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea S.","family":"de Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea R.","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo T.","family":"de Holanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrique H.","family":"Veloso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda S.N.S.","family":"Mendes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filipe A.C.","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcio N.","family":"Boia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro E.A.A.","family":"Brasil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda M.","family":"Carneiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilberto M.Sperandio","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro F.F.","family":"Mediano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eclinm.2020.100694_bib0001","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.actatropica.2016.01.002","article-title":"A global systematic review of Chagas disease prevalence among migrants","volume":"156","author":"Conners","year":"2016","journal-title":"Acta Tropica"},{"key":"10.1016\/j.eclinm.2020.100694_bib0002","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.idc.2018.10.015","article-title":"Morillo CA.American trypanosomiasis (Chagas disease)","volume":"33","author":"Echeverria","year":"2019","journal-title":"Infect. Dis. Clin. North Am."},{"key":"10.1016\/j.eclinm.2020.100694_bib0003","unstructured":"Pan American Health Organization. PAHO New guide for diagnosis and treatment of Chagas disease. 2019 [Internet]. Available in: https:\/\/www.paho.org\/hq\/index.php?option=com_content&view=article&id=14906:paho-issues-new-guide-for-diagnosis-and-treatment-of-chagas-disease<emid=135&lang=pt"},{"key":"10.1016\/j.eclinm.2020.100694_bib0004","article-title":"Trypanocidal treatment of Chagas disease","author":"P\u00e9rez-Molina","year":"2020","journal-title":"Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"},{"issue":"9","key":"10.1016\/j.eclinm.2020.100694_bib0005","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/j.1365-3156.2012.03025.x","article-title":"Antiparasitical chemotherapy in Chagas\u2019 disease cardiomyopathy: current evidence","volume":"17","author":"Matta Guedes","year":"2012","journal-title":"Tropical Med Int Health"},{"key":"10.1016\/j.eclinm.2020.100694_bib0006","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.1073\/pnas.92.8.3541","article-title":"Autoimmunity in Chagas disease cardiopathy: biological relevance of a cardiac myosin-specific epitope crossreactive to an immunodominant Trypanosoma cruzi antigen","volume":"92","author":"Cunha-Neto","year":"1995","journal-title":"Proc Nat Acad Sci"},{"issue":"1","key":"10.1016\/j.eclinm.2020.100694_bib0007","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0002-8703(94)90521-5","article-title":"Treatment of chronic Chagas\u2019 disease with benznidazole: clinical and serologic evolution of patients with long-term follow-up","volume":"127","author":"Viotti","year":"1994","journal-title":"Am Heart J"},{"issue":"3","key":"10.1016\/j.eclinm.2020.100694_bib0008","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0169-4758(99)01398-8","article-title":"Chagas disease etiology: autoimmunity or parasite persistence?","volume":"15","author":"Tarleton","year":"1999","journal-title":"Parasitology Today"},{"issue":"2","key":"10.1016\/j.eclinm.2020.100694_bib0009","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1128\/AAC.01662-13","article-title":"Towards a paradigm shift in the treatment of chronic chagas disease","volume":"58","author":"Viotti","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"10.1016\/j.eclinm.2020.100694_bib0010","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1161\/CIRCULATIONAHA.106.624296","article-title":"Pathogenesis of chronic chagas heart disease","volume":"115","author":"Marin-Neto","year":"2007","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.eclinm.2020.100694_bib0011","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/1054-8807(93)90021-S","article-title":"Correlation between Trypanosoma cruzi parasitism and myocardial inflammatory infiltrate in human chronic chagasic myocarditis: light microscopy and immunohistochemical findings","volume":"2","author":"Higuchi","year":"1993","journal-title":"Cardiovascular Pathology"},{"issue":"1","key":"10.1016\/j.eclinm.2020.100694_bib0012","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/jeu.12184","article-title":"Recent clinical trials for the etiological treatment of chronic chagas disease: advances, challenges and perspectives","volume":"62","author":"Urbina","year":"2015","journal-title":"J Eukaryot Microbiol"},{"issue":"1\u20132","key":"10.1016\/j.eclinm.2020.100694_bib0013","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.actatropica.2009.10.023","article-title":"Specific chemotherapy of Chagas disease: relevance, current limitations and new approaches","volume":"115","author":"Urbina","year":"2010","journal-title":"Acta Tropica"},{"issue":"3","key":"10.1016\/j.eclinm.2020.100694_bib0014","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1590\/0074-02760160334","article-title":"Chronic Chagas cardiomyopathy: a review of the main pathogenic mechanisms and the efficacy of aetiological treatment following the BENznidazole Evaluation for Interrupting Trypanosomiasis (BENEFIT) trial","volume":"112","author":"Rassi Jr","year":"2017","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.eclinm.2020.100694_bib0015","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1128\/AAC.49.4.1521-1528.2005","article-title":"Treatment with benznidazole during the chronic phase of experimental Chagas\u2019 disease decreases cardiac alterations","volume":"49","author":"Garcia","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"issue":"11","key":"10.1016\/j.eclinm.2020.100694_bib0016","doi-asserted-by":"crossref","first-page":"e1870","DOI":"10.1371\/journal.pntd.0001870","article-title":"Fexinidazole: a potential new drug candidate for chagas disease. Pollastri MP, organizador","volume":"6","author":"Bahia","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.eclinm.2020.100694_bib0017","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3389\/fcimb.2020.00210","article-title":"Precision health for Chagas disease: integrating parasite and host factors to predict outcome of infection and response to therapy","volume":"10","author":"Martinez","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"issue":"6","key":"10.1016\/j.eclinm.2020.100694_bib0018","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1093\/jac\/dkp357","article-title":"Use of benznidazole to treat chronic Chagas\u2019 disease: a systematic review with a meta-analysis","volume":"64","author":"P\u00e9rez-Molina","year":"2009","journal-title":"J Antimicrobial Chemotherapy"},{"issue":"10","key":"10.1016\/j.eclinm.2020.100694_bib0019","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0139363","article-title":"Course of Chronic trypanosoma cruzi infection after treatment based on parasitological and serological tests: a systematic review of follow-up studies. Cunha-Neto E, organizador","volume":"10","author":"Sguassero","year":"2015","journal-title":"PLoS ONE"},{"issue":"15","key":"10.1016\/j.eclinm.2020.100694_bib0020","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1080\/14656566.2019.1650915","article-title":"An evaluation of benznidazole as a Chagas disease therapeutic","volume":"20","author":"Caldas","year":"2019","journal-title":"Expert Opin Pharmacotherapy"},{"key":"10.1016\/j.eclinm.2020.100694_bib0021","doi-asserted-by":"crossref","unstructured":"Villar JC, Perez JG, Cortes OL, Riarte A, Pepper M, Marin-Neto JA, et\u00a0al. Trypanocidal drugs for chronic asymptomatic Trypanosoma cruzi infection. Cochrane Heart Group, organizer. Cochrane Database Systemat Rev. 2014 [Internet]. Available in: http:\/\/doi.wiley.com\/10.1002\/14651858.CD003463.pub2","DOI":"10.1002\/14651858.CD003463.pub2"},{"issue":"2","key":"10.1016\/j.eclinm.2020.100694_bib0022","first-page":"27","article-title":"Criterios de cura en la enfermedad de Chagas: interpretaci\u00f3n de hallazgos parasitol\u00f3gicos, serol\u00f3gicos y cl\u00ednicos","volume":"34","author":"Espinoza M","year":"2003","journal-title":"Revista del Instituto Nacional de Higiene Rafael Rangel"},{"key":"10.1016\/j.eclinm.2020.100694_bib0023","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/S0140-6736(96)04128-1","article-title":"Randomized trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection","volume":"348","author":"Sgambatti de Andrade","year":"1996","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.eclinm.2020.100694_bib0024","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1590\/0074-0276130122","article-title":"A serological, parasitological and clinical evaluation of untreated Chagas disease patients and those treated with benznidazole before and thirteen years after intervention","volume":"108","author":"Machado-de-Assis","year":"2013","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"1","key":"10.1016\/j.eclinm.2020.100694_bib0025","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1186\/s13063-020-4226-2","article-title":"Efficacy and safety assessment of different dosage of benznidazol for the treatment of Chagas disease in chronic phase in adults (MULTIBENZ study): study protocol for a multicenter randomized Phase II non-inferiority clinical trial","volume":"21","author":"Molina-Morant","year":"2020","journal-title":"Trials"},{"issue":"8","key":"10.1016\/j.eclinm.2020.100694_bib0026","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.jacc.2016.12.023","article-title":"Benznidazole and posaconazole in eliminating parasites in asymptomatic T. Cruzi Carriers","volume":"69","author":"Morillo","year":"2017","journal-title":"J Am College Cardiol"},{"issue":"20","key":"10.1016\/j.eclinm.2020.100694_bib0027","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1056\/NEJMoa1313122","article-title":"Randomized trial of posaconazole and benznidazole for chronic Chagas\u2019 disease","volume":"370","author":"Molina","year":"2014","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.eclinm.2020.100694_bib0028","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S1473-3099(17)30538-8","article-title":"Treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens: a proof-of-concept, randomised, placebo-controlled trial","volume":"18","author":"Torrico","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"10.1016\/j.eclinm.2020.100694_bib0029","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008529","article-title":"Fixed vs adjusted-dose benznidazole for adults with chronic Chagas disease without cardiomyopathy: a systematic review and meta-analysis","volume":"14","author":"Ciapponi","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"10.1016\/j.eclinm.2020.100694_bib0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008067","article-title":"Usefulness of real-time PCR during follow-up of patients treated with Benznidazole for chronic Chagas disease: experience in two referral centers in Barcelona.","volume":"14","author":"Sulleiro","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"issue":"11","key":"10.1016\/j.eclinm.2020.100694_bib0031","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1007\/s10096-016-2733-6","article-title":"Success of benznidazole chemotherapy in chronic Trypanosoma cruzi-infected patients with a sustained negative PCR result","volume":"35","author":"Murcia","year":"2016","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"6","key":"10.1016\/j.eclinm.2020.100694_bib0032","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/trstmh\/trt029","article-title":"Clinical characteristics and outcome of 107 adult patients with chronic Chagas disease and parasitological cure criteria","volume":"107","author":"Bertocchi","year":"2013","journal-title":"Trans R Soc Trop Med Hygiene"},{"key":"10.1016\/j.eclinm.2020.100694_bib0033","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00439-20","article-title":"New scheme of intermittent benznidazole administration in patients chronically infected with Trypanosoma cruzi: clinical, parasitological and serological assessment after three years of follow-up","author":"\u00c1lvarez","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.eclinm.2020.100694_bib0034","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s10096-011-1393-9","article-title":"Dealing with initial inconclusive serological results for chronic Chagas disease in clinical practice","volume":"31","author":"Lapa","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.eclinm.2020.100694_bib0035","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1590\/S0037-86822011000800007","article-title":"The electrocardiographic survey","volume":"44","author":"Gon\u00e7alves","year":"2011","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"10.1016\/j.eclinm.2020.100694_bib0036","first-page":"7","article-title":"2nd Brazilian consensus on chagas disease","volume":"25","author":"Dias","year":"2016","journal-title":"2015. Epidemiol Serv Sa\u00fade"},{"issue":"1","key":"10.1016\/j.eclinm.2020.100694_bib0037","first-page":"47","article-title":"Eletrocardiographic classification and abbreviated lead system for population-based studies of Chagas disease","volume":"16","author":"Maguire","year":"1982","journal-title":"Bull Pan Am Health Organ"},{"issue":"4","key":"10.1016\/j.eclinm.2020.100694_bib0038","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1161\/hc0402.102975","article-title":"Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the cardiac imaging committee of the council on clinical cardiology of the american heart association","volume":"105","author":"Cerqueira","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.eclinm.2020.100694_bib0039","first-page":"33","article-title":"Influ\u00eancia da exposi\u00e7\u00e3o \u00e0 reinfec\u00e7\u00e3o na evolu\u00e7\u00e3o da doen\u00e7a de Chagas. Estudo longitudinal de 5 anos","volume":"5","author":"Macedo","year":"1976","journal-title":"Revista de Patologia Tropical"},{"issue":"1","key":"10.1016\/j.eclinm.2020.100694_bib0040","doi-asserted-by":"crossref","first-page":"36","DOI":"10.5334\/gh.793","article-title":"Myocardial involvement in chagas disease and insulin resistance: a non-metabolic model of cardiomyopathy","volume":"15","author":"Echeverr\u00eda","year":"2020","journal-title":"Global Heart"},{"issue":"8","key":"10.1016\/j.eclinm.2020.100694_bib0041","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.15072","article-title":"Risk of chronic cardiomyopathy among patients with the acute phase or indeterminate form of chagas disease: a systematic review and meta-analysis","volume":"3","author":"Chadalawada","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"6","key":"10.1016\/j.eclinm.2020.100694_bib0042","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1590\/S0074-02762011000600001","article-title":"Chronic phase of Chagas disease: why should it be treated? A comprehensive review","volume":"106","author":"Coura","year":"2011","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"2","key":"10.1016\/j.eclinm.2020.100694_bib0043","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ofid\/ofz012","article-title":"Progression of baseline electrocardiogram abnormalities in chagas patients undergoing antitrypanosomal treatment","volume":"6","author":"Soverow","year":"2019","journal-title":"Open Forum Infect Dis"},{"issue":"10","key":"10.1016\/j.eclinm.2020.100694_bib0044","doi-asserted-by":"crossref","first-page":"724","DOI":"10.7326\/0003-4819-144-10-200605160-00006","article-title":"Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment: a nonrandomized trial","volume":"144","author":"Viotti","year":"2006","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.eclinm.2020.100694_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1590\/S0037-86822007000100001","article-title":"Trypanocide treatment among adults with chronic Chagas disease living in Santa Fe City (Argentina), over a mean follow-up of 21 years: parasitological, serological and clinical evolution","volume":"40","author":"Fabbro","year":"2007","journal-title":"Rev Soc Bras Med Trop"},{"issue":"3","key":"10.1016\/j.eclinm.2020.100694_bib0046","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004508","article-title":"Evaluation of parasiticide treatment with Benznidazol in the electrocardiographic, clinical, and serological evolution of chagas disease","volume":"10","author":"Fragata-Filho","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"10.1016\/j.eclinm.2020.100694_bib0047","first-page":"359","article-title":"Hist\u00f3ria natural da doen\u00e7a de Chagas","volume":"65","author":"Dias","year":"1995","journal-title":"Arq Bras Cardiol"},{"issue":"10","key":"10.1016\/j.eclinm.2020.100694_bib0048","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1161\/CIRCULATIONAHA.112.123612","article-title":"Ten-year Incidence of Chagas cardiomyopathy among asymptomatic, T. Cruzi seropositive former blood donors","volume":"127","author":"Sabino","year":"2013","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.eclinm.2020.100694_bib0049","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1590\/0037-8682-0184-2018","article-title":"Electrocardiogram in Chagas disease","volume":"51","author":"Brito","year":"2018","journal-title":"Rev Soc Bras Med Trop"},{"issue":"11","key":"10.1016\/j.eclinm.2020.100694_bib0050","doi-asserted-by":"crossref","first-page":"6371","DOI":"10.1128\/AAC.02842-14","article-title":"A clinical adverse drug reaction prediction model for patients with chagas disease treated with benznidazole","volume":"58","author":"Sperandio da Silva","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.eclinm.2020.100694_bib0051","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.echo.2018.09.006","article-title":"Effects of trypanocidal treatment on echocardiographic parameters in chagas cardiomyopathy and prognostic value of wall motion score index: a benefit trial echocardiographic substudy","volume":"32","author":"Schmidt","year":"2019","journal-title":"J Am Soc Echocardiogr"},{"issue":"1","key":"10.1016\/j.eclinm.2020.100694_bib0052","first-page":"29","article-title":"Comparacion de mortalidad durante seguimiento por 5 a\u00f1os en sujetos con enfermedad de Chagas cr\u00f3nica con y sin tratmiento de benzonidazol","volume":"27","author":"Catalioti","year":"1998","journal-title":"J Tropic Pathol"}],"container-title":["EClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537020304387?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537020304387?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T19:05:22Z","timestamp":1762887922000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537020304387"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":52,"alternative-id":["S2589537020304387"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2020.100694","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Benznidazole decreases the risk of chronic Chagas disease progression and cardiovascular events: A long-term follow up study","name":"articletitle","label":"Article Title"},{"value":"EClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2020.100694","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100694"}}